Prana continues Alzheimer's drug trial in Australia

07/4/2013 | RTT News · Bloomberg Businessweek

An Australian hospital has cleared Prana Biotechnology's request to conduct a 12-month extension study of PBT2, the company's Alzheimer's disease drug candidate. PET imaging will be used to examine changes in the brains of Alzheimer's patients who have received PBT2 treatment for 12 months as part of the company's IMAGINE trial.

View Full Article in:

RTT News · Bloomberg Businessweek

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR